With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Investigating Epigenetic Mechanisms of Response to Allogenic CAR T Cell Therapy||St. Jude Children's Research Hospital / Caitlin Zebley, MD/PhD||Young Investigator Grants||2021||Tennessee|
|Novel Genomic Diagnostics for Intracranial Germ Cell Tumors||Connecticut Children's Medical Center Foundation, Inc. / Ching Lau, MD/PhD||Reach Grants||2021||Connecticut|
|Hematopoietic Stem And Progenitor Cells Sustain Inflammation And Promote Relapse In The AML Niche||Children's Hospital of Philadelphia / Ding-Wen (Roger) Chen, PhD||Young Investigator Grants||2021||Pennsylvania|
|Dual PTK7/GD2 Gamma Delta CAR T Cell Therapy for Neuroblastoma||Emory University / Kelly Goldsmith, MD & H. Trent Spencer, PhD & Chris B. Doering, PhD||Reach Grants||2021||Georgia|
|STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma||University of California San Francisco / Elizabeth Young, MD||Young Investigator Grants||2021||California|
|Stapled Peptide PROTAC: A 3-in-1 Treatment for Pediatric Solid Tumors||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Reach Grants||2021||Massachusetts|
|Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG||Mayo Clinic / David Daniels, MD/PhD||Reach Grants||2021||Minnesota|
|Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells||Children's Hospital of Pittsburgh / Erica Braverman, MD||Young Investigator Grants||2021||Pennsylvania|
|IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas||Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD||Reach Grants||2021||New York|
|Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies||Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD||Young Investigator Grants||2021||Ohio|